Jinglei Li

Jinglei Li

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
WGWei Gu
Wei Gu
CLChuan Liu
Chuan Liu
JLJinglei Li
Jinglei Li
JWJian Wang
Jian Wang
Background: Head and neck squamous cell carcinoma (HNSCC) responds poorly (<20%) to immune checkpoint blockade. Since sialylation suppresses anti-tumour immunity through Siglec signalling independently of the PD-L1/PD-1 axis, we mapped its prognostic landscape in HNSCC by integrating prognostic modelling, molecular subtyping, and AI-guided drug discovery. Methods: Transcriptomic data from seven GEO cohorts and TCGA-HNSC (n = 501) were analysed with a 1204-gene sialylation compendium. The Sialylation Niche Index (SNI) was built in TCGA-HNSC from 117 machine-learning algorithm combinations (nominally 101), with survival-based feature selection and model fitting confined to the training set; model selection used TCGA-HNSC and the external model-selection cohort GSE42743 (n = 74 with overall survival), and the three independent test cohorts were scored without re-fitting (E-MTAB-8588, n = 83; GSE65858, n = 270; and GSE41613, n = 97). Key model genes were characterised by single-cell RNA sequencing (168,742 cells), spatial transcriptomics, and AI-guided screening of 249,455 compounds. Results: Thirty-one prognostic sialylation-associated DEGs defined an immunosuppressive subtype (C1) and an immune-active subtype (C2) with divergent survival. The SNI achieved a C-index of 0.88 in TCGA-HNSC, 0.68 in GSE42743, and 0.58–0.62 in the three independent test cohorts and remained independently prognostic after adjustment for age and other clinicopathological variables in multivariable analysis. SHAP analysis identified HSPH1 (risk-associated) and ST6GALNAC1 (protective) as principal contributors with opposing microenvironmental associations. Conclusions: Sialylation constitutes a distinct immunosuppressive axis in HNSCC, complementary to PD-1 blockade. The SNI provides a biologically anchored prognostic framework whose cross-platform transfer requires recalibration; putative candidate compounds require experimental validation.

15 September 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
WGWei Gu
Wei Gu
JLJinglei Li
Jinglei Li
CLChuan Liu
Chuan Liu
CCChuan Chen
Chuan Chen
JWJian Wang
Jian Wang
Background: Allergic rhinitis is common and clinically heterogeneous, but the genes whose genetically regulated immune-state expression influences susceptibility remain incompletely resolved. Methods: We integrated dynamic CD4+ T cell eQTL data (46 activation-state profiles) with allergic rhinitis GWAS summary statistics, applying transcriptome-wide Mendelian randomization (MR), colocalization, SMR/HEIDI, metabolite screening, paired single-cell RNA-seq and TCR analysis, and computational follow-up. Colocalization support was prespecified as conditional ratio PP.H4/(PP.H3 + PP.H4) > 0.7; HEIDI at p > 0.05. Results: After MHC-region exclusion, 50,654 gene-profile pairs were tested and 129 MR-significant genes were identified. Colocalization supported 418 pairs (111 genes); 70 genes passed both SMR and HEIDI; and cross-database comparison yielded a nine-gene overlap set. In GSE200107, baseline good-versus-poor responder differences were larger than treatment-induced transcriptional change; patient-level reanalysis found no pair surviving multiple-testing correction (n = 4 vs. 3); these findings are hypothesis-generating. Paired TCR analysis suggested greater clonotype renewal in good responders (descriptive). Structure-guided screening prioritized unvalidated binder candidates for SLC25A46 and TLR1 (TLR1 TIR docking −5.86 kcal/mol; MD RMSD 0.20 nm). Conclusions: An exploratory metabolite screen yielded nominally significant indirect-effect signals, but the candidate metabolite did not colocalize with the disease locus. This framework prioritizes candidate therapeutic targets for allergic rhinitis.

2 June 2026 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
CLChuan Liu
Chuan Liu
JLJinglei Li
Jinglei Li
CCChuan Chen
Chuan Chen
WGWei Gu
Wei Gu
JWJian Wang
Jian Wang
Purpose: Head and neck unicentric Castleman disease (HN-UCD) often lacks specific clinical and laboratory markers, leading to frequent preoperative misdiagnoses. While surgical resection typically offers a favorable prognosis, the management of atypical postoperative outcomes, such as new regional lymphadenopathy or persistent systemic symptoms, remains poorly defined. This study aimed to identify the characteristic imaging features of HN-UCD and explore effective management strategies for these atypical postoperative scenarios. Methods: A retrospective analysis was conducted on 24 patients diagnosed with HN-UCD at the Peking Union Medical College Hospital over the past 20 years. The preoperative imaging characteristics and postoperative clinical outcomes were systematically evaluated. Results: Imaging confirmed significant hypervascularity as a hallmark of HN-UCD: 94.4% (17/18) of lesions exhibited abundant and disordered blood flow signals on ultrasound, and 71.4% (10/14) of lesions presented with prominent feeding vessels on CT. Postoperatively, 87.5% (21/24) of the patients achieved complete remission within the surgical field. For the two patients exhibiting atypical outcomes (new regional lymphadenopathy and persistent fever), a strategy of rigorous follow-up was adopted after multidisciplinary exclusion of malignancy and infection; both patients remained clinically stable. Conclusion: Prominent feeding vessels and marked hypervascularity are characteristic preoperative imaging markers for HN-UCD. For patients with atypical postoperative outcomes, a management protocol based on multidisciplinary evaluation and close clinical observation is recommended.